YKL40as a therapeutic target for the treatment of metastatic Prostate Cancer

被引:0
|
作者
Jeet, Varinder [1 ]
Nelson, Colleen Coyne [1 ]
机构
[1] Queensland Univ Technol, Brisbane, Qld 4001, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:45 / 45
页数:1
相关论文
共 50 条
  • [31] Recommendations for clinical practice -: Therapeutic treatment of non-metastatic prostate cancer
    Soulie, M.
    Beuzeboc, P.
    Richaud, P.
    Villers, A.
    Kassab-Chahmi, D.
    Bataillard, A.
    Cornud, F.
    de Fromont, M.
    Gravis, G.
    Hennequin, C.
    Molinie, V.
    Mongiat-Artus, P.
    Muratet, J-P.
    du Chatelard, P-M. Pabot
    Prapotnich, D.
    Rebillard, X.
    Rossi, D.
    BULLETIN DU CANCER, 2006, 93 (10) : 1007 - 1015
  • [32] Future therapeutic strategies for metastatic prostate cancer
    Smits M.
    Gerritsen W.
    Mehra N.
    Tijdschrift voor Urologie, 2019, 9 (6-7) : 117 - 130
  • [33] Metastatic prostate cancer remains a therapeutic challenge
    Heidenreich, Axel
    AKTUELLE UROLOGIE, 2024, 55 (02) : 81 - 81
  • [34] Novel therapeutic approaches for metastatic prostate cancer
    Bokemeyer, C.
    ONKOLOGIE, 2012, 35 : 2 - 2
  • [35] The Current Therapeutic Landscape for Metastatic Prostate Cancer
    Bernal, Anastasia
    Bechler, Alivia Jane
    Mohan, Kabhilan
    Rizzino, Angie
    Mathew, Grinu
    PHARMACEUTICALS, 2024, 17 (03)
  • [36] B7H3 is a potential therapeutic target in advanced metastatic prostate cancer
    Agarwal, Supreet
    Fang, Lei
    Yin, Juan Juan
    Hurt, Elaine
    Kelly, Kathleen
    CANCER RESEARCH, 2022, 82 (12)
  • [37] CDK8/CDK19 inhibition as therapeutic target of metastatic prostate cancer
    Offermann, A.
    Becker, F.
    Kluemper, N.
    Vogel, W.
    Braegelmann, J.
    Perner, S.
    VIRCHOWS ARCHIV, 2017, 471 : S269 - S269
  • [38] TenB2 as a therapeutic antibody drug target for the treatment of prostate cancer
    Mao, Weiguang
    Yu, ShangFan
    Inigo, Ivan
    Lin, Kedan
    Kozak, Kathy
    Leach, Will
    McDorman, Elena
    Fuji, Reina
    Junutula, Jagath Reddy
    Koeppen, Hartmut
    Polakis, Paul
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3356S - 3356S
  • [39] Adiponectin as a Potential Therapeutic Target for Prostate Cancer
    Karnati, Hanuma Kumar
    Panigrahi, Manas Kumar
    Li, Yazhou
    Tweedie, David
    Greig, Nigel H.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (28) : 4170 - 4179
  • [40] KIT as a therapeutic target in neuroendocrine prostate cancer
    Azad, Arun A.
    Kostos, Louise
    Agarwal, Neeraj
    CANCER CELL, 2022, 40 (11) : 1266 - 1268